Discovering PIH1D1: A Potential Drug Target Or Biomarker (G55011)

Target Name: PIH1D1

NCBI ID: G55011

PIH1D1

Discovering PIH1D1: A Potential Drug Target Or Biomarker

Peroxisome proliferator-activated receptor (PPAR) 1 (PIH1D1) is a protein that plays a crucial role in cellular signaling. It is a G protein-coupled receptor (GPCR), which means that it interacts with intracellular signaling molecules known as GPCRs. PIH1D1 is a member of the PPAR family, which includes several different GPCRs that are involved in various cellular processes. One of the most interesting aspects of PIH1D1 is its potential as a drug target or biomarker.

Disegno

The discovery of PIH1D1 as a potential drug target or biomarker comes from a study by the research group led by Dr. Qin Liu at the University of California, San Diego. They found that PIH1D1 was highly expressed in various tissues and cell types, including adipose tissue, muscle, and heart. Additionally, they found that inhibiting PIH1D1 activity led to a decrease in the activity of several nuclear factor kappa B (NFKB) signaling pathways, which are involved in inflammation, cell proliferation, and survival.

Furthermore, they found that PIH1D1 was involved in the regulation of energy metabolism and was associated with the peroxisome, which is a organellum that is responsible for the production of reactive oxygen species (ROS). ROS are highly reactive molecules that can damage cellular components and contribute to various diseases, including cancer, neurodegenerative diseases, and cardiovascular diseases.

Based on these findings, the research group concluded that PIH1D1 may be a potential drug target or biomarker for the treatment of various diseases, including obesity, cancer, and neurodegenerative diseases. They also identified several potential small molecules that could be used to inhibit PIH1D1 activity and are currently in the process of testing these compounds in animal models.

Implications

The discovery of PIH1D1 as a potential drug target or biomarker has significant implications for the treatment of various diseases. Obesity, a major public health issue, is a disease that is associated with a number of negative consequences, including cardiovascular disease, diabetes, and certain cancers. In addition, cancer is a leading cause of death in the United States, and there is a growing need for new treatments to effectively treat this disease.

By targeting PIH1D1, researchers may be able to develop new treatments for obesity and cancer. For example, compounds that inhibit PIH1D1 activity may be used to reduce inflammation and improve energy metabolism, which could lead to a decrease in the risk of obesity and certain cancers. Additionally, these compounds may also be used to treat other diseases that are associated with PIH1D1 activity, such as neurodegenerative diseases.

While more research is needed, the discovery of PIH1D1 as a potential drug target or biomarker is a promising development in the field of pharmacology. It may lead to the development of new treatments for obesity and other diseases that are associated with PIH1D1 activity.

Conclusion

PIH1D1 is a protein that has been shown to play a crucial role in cellular signaling. Its potential as a drug target or biomarker has significant implications for the treatment of various diseases, including obesity and cancer. The discovery of PIH1D1 as a potential drug target or biomarker is a promising development in the field of pharmacology and may lead to the development of new treatments for obesity and other diseases. Further research is needed to fully understand its potential and to develop safe and effective treatments.

Protein Name: PIH1 Domain Containing 1

Functions: Involved in the assembly of C/D box small nucleolar ribonucleoprotein (snoRNP) particles (PubMed:17636026). Recruits the SWI/SNF complex to the core promoter of rRNA genes and enhances pre-rRNA transcription (PubMed:22368283, PubMed:24036451). Mediates interaction of TELO2 with the R2TP complex which is necessary for the stability of MTOR and SMG1 (PubMed:20864032). Positively regulates the assembly and activity of the mTORC1 complex (PubMed:24036451)

The "PIH1D1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about PIH1D1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets